Medical Microbiology and Immunology

, Volume 196, Issue 2, pp 95–102 | Cite as

Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections

  • A. SauerbreiEmail author
  • P. Wutzler
Original Investigation


Varicella during pregnancy can be associated with severe illnesses for both the mother and her neonate. Varicella pneumonia must be regarded as a medical emergency, since pregnant women are at risk of life-threatening ventilatory compromise and death. After maternal chickenpox in the first and second trimesters, congenital varicella syndrome may occur in nearly 2% of the cases. The characteristic symptoms consist of skin lesions in dermatomal distribution, neurological defects, eye diseases and skeletal anomalies. If the mother develops varicella rashes between day 4 (5) antepartum and day 2 postpartum, generalized neonatal varicella leading to death in about 20% of the cases has to be expected. Normal zoster has not been shown to be associated with maternal pneumonia, birth defects or problems in the perinatal period. On the basis of the clinical consequences of varicella-zoster virus infections during pregnancy, the present paper summarizes the currently available concepts of prevention, diagnosis and therapy.


Varicella-zoster virus infection Pregnancy Neonate Prevention Diagnosis Therapy 


  1. 1.
    Advisory committee on immunization practices (ACIP) (1996) Prevention of varicella. MMWR Recomm Rep 45:1–36Google Scholar
  2. 2.
    Akisu M, Yalaz M, Aksu G, Arslanoglu S, Genel F, Kutukculer N, Kultursay N (2003) Maternally acquired varicella-zoster virus antibodies disappear at 6 months of age in prematurely born children. Panminerva Med 45:155–156PubMedGoogle Scholar
  3. 3.
    Al-Katawee YA, Al-Hassoun YA, Taha MN, Al-Moslem K (2005) Congenital varicella-zoster virus infection. A rare case of severe brain and ocular malformations without limb or cutaneous involvement in a newborn after maternal subclinical infection. Saudi Med J 26:869–871PubMedGoogle Scholar
  4. 4.
    Baba K, Yabuuchi H, Takahashi M, Ogra PL (1982) Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood. J Pediatr 100:881–885PubMedCrossRefGoogle Scholar
  5. 5.
    Carter PE, Duffty P, Lloyd DJ (1986) Neonatal varicella infection. Lancet 2:1459–1460PubMedCrossRefGoogle Scholar
  6. 6.
    Chandra PC, Patel H, Schiavello HJ, Briggs SL (1998) Successful pregnancy outcome after complicated varicella pneumonia. Obstet Gynecol 92:680–682PubMedCrossRefGoogle Scholar
  7. 7.
    Deutsche Gesellschaft für Pädiatrische Infektiologie (2003) Handbuch 2003: Infektionen im Kindesalter. Futuramed, München, pp 732–739Google Scholar
  8. 8.
    Enders G, Miller E (2000) Varicella and herpes zoster in pregnancy and the newborn. In: Arvin AM, Gershon AA (eds) Varicella-zoster virus. Virology and clinical management. University Press, Cambridge, pp. 317–347Google Scholar
  9. 9.
    Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M (1994) Consequences of varicella and herpes zoster in pregnancy: prospective study of 1,739 cases. Lancet 343:1548–1551PubMedCrossRefGoogle Scholar
  10. 10.
    Gershon AA (1998) Varicella-zoster virus. In: Feigin RD, Cherry JD (eds) Textbook of pediatric infectious diseases, 4th edn. W. B. Saunders Company, Philadelphia, pp 1769–1777Google Scholar
  11. 11.
    Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM (1976) Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life. Pediatrics 58:692–696PubMedGoogle Scholar
  12. 12.
    Grose C (1989) Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity. Mol Biol Med 6:453–462PubMedGoogle Scholar
  13. 13.
    Gross G, Schofer H, Wassilev S, Friese K, Timm A, Guthoff R, Pau HW, Malin JP, Wutzler P, Doerr HW (2003) Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 26:277–289PubMedCrossRefGoogle Scholar
  14. 14.
    Heidl M (1985) Varicella-Zoster-Virus-Infektion in der Schwangerschaft, beim Neugeborenen und jungen Säugling. Z Klin Med 40:245–250Google Scholar
  15. 15.
    Higa K, Dan K, Manabe H (1987) Varicella-zoster virus infections during pregnancy: hypothesis concerning the mechanisms of congenital malformation. Obstet Gynecol 69:214–221PubMedGoogle Scholar
  16. 16.
    Holland P, Isaacs D, Moxon ER (1986) Fatal neonatal varicella infection. Lancet 2:1156PubMedCrossRefGoogle Scholar
  17. 17.
    Hubbard TW (1878) Varicella occurring in an infant 24 h after birth. Br Med J 1:822Google Scholar
  18. 18.
    Johansson AB, Rassart A, Blum D, Van Beers D, Liesnard C (2004) Lower-limb hypoplasia due to intrauterine infection with herpes simplex virus type 2: possible confusion with intrauterine varicella-zoster syndrome. Clin Infect Dis 38:e57–e62PubMedCrossRefGoogle Scholar
  19. 19.
    King SM, Gorensek M, Ford-Jones EL, Read SE (1986) Fatal varicella-zoster infection in a newborn treated with varicella-zoster immunoglobulin. Pediatr Infect Dis 5:588–589PubMedCrossRefGoogle Scholar
  20. 20.
    Koskimies O, Lapinleimu K, Saxén L (1978) Infections and other maternal factors as risk indicators for congenital malformations: a case-control study with paired serum samples. Pediatrics 61:832–837PubMedGoogle Scholar
  21. 21.
    Kuter BJ, Ngai A, Patterson CM, Staehle BO, Cho I, Matthews H, Provost PJ, White CJ (1995) Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax®) in healthy adolescents and adults. Vaccine 13:967–972PubMedCrossRefGoogle Scholar
  22. 22.
    Laforet EG, Lynch CJ Jr (1947) Multiple congenital defects following maternal varicella. N Engl J Med 236:534–537PubMedCrossRefGoogle Scholar
  23. 23.
    Miller E (1994) Varicella-zoster virus infection in pregnancy. Arch Dis Child 70:F157–F158CrossRefGoogle Scholar
  24. 24.
    Miller E, Cradock-Watson JE, Ridehalgh MK (1989) Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 2:371–373PubMedCrossRefGoogle Scholar
  25. 25.
    Mouly F, Mirlesse V, Meritet JF, Rozenberg F, Poissonier MH, Lebon P, Daffos F (1997) Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 177:894–898PubMedCrossRefGoogle Scholar
  26. 26.
    Pastuszak AL, Levy M, Schick B, Zuber C, Feldkamp M, Gladstone J, Bar-Levy F, Jackson E, Donnenfeld A, Meschino W, Koren G (1994) Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 330:901–905PubMedCrossRefGoogle Scholar
  27. 27.
    Paulman PM, McLellan R (1990) Varicella during pregnancy: the timing of effective treatment. J Am Board Fam Pract 3:121–123PubMedGoogle Scholar
  28. 28.
    Pretorius DH, Hayward I, Jones KL, Stamm E (1992) Sonographic evaluation of pregnancies with maternal varicella infection. J Ultrasound Med 11:459–463PubMedGoogle Scholar
  29. 29.
    Prober CG, Gershon AA, Grose C, McCracken GH, Nelson JD (1990) Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J 9:865–869PubMedCrossRefGoogle Scholar
  30. 30.
    Robert Koch-Institut (2004) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2004. Epidemiol Bull 30:235–250Google Scholar
  31. 31.
    Royal College of Obstetricians and Gynecologists (2001) Guideline no. 13, Chickenpox in pregnancyGoogle Scholar
  32. 32.
    Sauerbrei A, Wutzler P (2000) The congenital varicella syndrome. J Perinatol 20:548–554PubMedCrossRefGoogle Scholar
  33. 33.
    Sauerbrei A, Wutzler P (2001) Neonatal varicella. J Perinatol 21:545–549PubMedCrossRefGoogle Scholar
  34. 34.
    Sauerbrei A, Wutzler P (2003) Das fetale Varizellensyndrom. Monatsschr Kinderheilkd 151:209–213CrossRefGoogle Scholar
  35. 35.
    Sauerbrei A, Wutzler P (2004) Labordiagnostik der Varizellen. Kinderärztl Prax Sonderh Impfen 18–21Google Scholar
  36. 36.
    Sauerbrei A, Wutzler P (2005) Varicella-zoster virus infections during pregnancy: epidemiology, clinical symptoms, diagnosis, prevention and therapy. Curr Pediatr Rev 1:205–216CrossRefGoogle Scholar
  37. 37.
    Sauerbrei A, Müller D, Eichhorn U, Wutzler P (1996) Detection of varicella-zoster virus in congenital varicella syndrome: a case report. Obstet Gynecol 88:687–689PubMedCrossRefGoogle Scholar
  38. 38.
    Sauerbrei A, Glück B, Jung K, Bittrich H, Wutzler P (2000) Congenital skin lesions caused by intrauterine coxsackie virus B3 infection: a case report. Infection 28:326–328PubMedCrossRefGoogle Scholar
  39. 39.
    Sauerbrei A, Pawlak J, Luger C, Wutzler P (2003) Intracerebral VZV reactivation in congenital varicella syndrome? A case report. Dev Med Child Neurol 45:837–840PubMedCrossRefGoogle Scholar
  40. 40.
    Schulze A, Dietzsch HJ (2000) The natural history of varicella embryopathy: a 25-year follow-up. J Pediatr 137:871–874PubMedCrossRefGoogle Scholar
  41. 41.
    Schulze-Oechtering F, Roth B, Enders G, Grosser R (2004) Kongenitales Varizellensyndrom—besteht eine Infektionsgefahr für die Umgebung? Dtsch Med Wochenschr 208:25–28Google Scholar
  42. 42.
    Sever J, White LR (1968) Intrauterine viral infections. Annu Rev Med 19:471–486PubMedCrossRefGoogle Scholar
  43. 43.
    Shields KE, Galil K, Seward J, Sharrar RG, Cordero JF, Slater E (2001) Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry. Obstet Gynecol 98:14–19PubMedCrossRefGoogle Scholar
  44. 44.
    Smego RA Jr, Asperille MO (1991) Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol 78:1112–1116PubMedGoogle Scholar
  45. 45.
    Spranger S, Stute H, Blankenagel A, Jauch A, Hager D, Tariverdian G (1998) MIDAS-Syndrom—Eine X-chromosomale Erkrankung. Differenzialdiagnose zum kongenitalen Varizellensyndrom. Monatsschr Kinderheilkd 146:761–765CrossRefGoogle Scholar
  46. 46.
    Tan MP, Koren G (2006) Chickenpox in pregnancy: revisited. Reprod Toxicol 21:410–420PubMedCrossRefGoogle Scholar
  47. 47.
    Vázquez M, Shapiro ED (2005) Varicella vaccine and infection with varicella-zoster virus. N Engl J Med 352:439–440PubMedCrossRefGoogle Scholar
  48. 48.
    Verstraelen H, Vanzieleghem B, Deroort P, Vanhaesebrouck P, Temmerman M (2003) Prenatal ultrasound and magnetic resonance imaging in fetal varicella syndrome: correlation with pathology findings. Prenat Diagn 23:705–709PubMedCrossRefGoogle Scholar
  49. 49.
    Watson B (2002) Varicella: a vaccine preventable disease? J Infect 44:220–225PubMedCrossRefGoogle Scholar
  50. 50.
    Wutzler P, Sauerbrei A, Scholz H, Müller D, Wiedersberg H (1990–1991) Varicella-Zoster-Virusinfektionen in der Schwangerschaft. Paediatr Prax 41:213–224Google Scholar
  51. 51.
    Wutzler P, Färber I, Wagenpfeil S, Bisanz H, Tischer A (2001) Seroprevalence of varicella-zoster virus in the German population. Vaccine 20:121–124PubMedCrossRefGoogle Scholar
  52. 52.
    Zieger W, Friese K, Weigel M, Becker KP, Melchert F (1994) Varizellen-Infektion am Geburtstermin. Z Geburtshilfe Perinatol 198:134–137PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  1. 1.Institute of Virology and Antiviral TherapyFriedrich-Schiller University of JenaJenaGermany

Personalised recommendations